GWAS: An Insight In To The Reproductive Health Of Women | 4654
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

GWAS: An insight in to the reproductive health of women

3rd World Congress on Biotechnology

Mahima Gulabani

Posters: Agrotechnol

DOI: 10.4172/2155-952X.S1.020

Puberty, the transition from childhood to adult body size and sexual maturity, is a complex multi-staged process. Epidemiological studies with regard to reproductive health often use age at menarche, to indicate the timing of puberty and age at natural menopause, marking the end of the pubertal period. Menarche (first menstrual period) and Menopause (end of menstruation) are the hallmark maturational (physiological) events in a female?s reproductive life. Throughout the last decades the interest in the mechanisms behind ovarian ageing and the timing of menarche and natural menopause has increased since both of them have great cultural, social, and epidemiological implications for women?s fertility, health and health risks. Genome-wide association (GWA) studies have been successful in identifying many common susceptibility genes and variants associated with complex disease and quantitative traits and we therefore use this approach to identify genes (LIN28B, MCM8, BRSK1 etc.), involved in determining age at menarche (AAM) and age at natural menopause (ANM). Anthropological studies on AAM and ANM provide inference about growth and pattern of women under particular ecological settings, having direct developmental application in improving population growth for various populations living under challenging conditions (like infectious disease, malnutrition etc.) by effectively controlling diseases affecting women?s reproductive period. Clinical epidemiologists can effectively design their randomized control trials for testing the efficacy of drugs affecting women?s reproductive health based on their genetic profiles. Genetic epidemiologists can enhance the value of epidemiological research by incorporating information about genetic differences in risk into accurate statistical prediction of the time of menarche and menopause. Further, Demographers study fertility in order to foresee the future health profile of the national population. Therefore, the data on the validation of the genetic markers on Indian population will help to remodel surveys according to the genetic-make up of women populations by incorporating more parameters. Broadly, this study will help in creating more women specific public health policies, and hence women empowerment.
Mahima Gulabani is a Graduate and Post-Graduate in Anthropology with specialisation in Physical or Biological Anthropology with an excellent academic record from the University of Delhi. I am currently a Junior Research Fellow at University of Delhi, pursuing my Ph.D. in Molecular Anthropology (Molecular genetics) with regard to genomic study related to women?s reproductive health among the Indian populations. I have published paper in reputed journal and some under communication.